Therefore, the long-term stroke and mortality rates observed in the included cohorts may partly reflect persistent IL-6–driven inflammatory activity, emphasizing that the benefit of CEA depends not only on mechanical plaque removal but also on the modulation of the patients’ systemic inflammatory state [17,18,37]. This evidence concerns the gene IL6 and stroke disorder.